The phenomenon of cross-border healthcare: a key challenge for pharmaceutical practice
Health systems remain to be discussed widely today in terms of quality, efficiency and safety of services provided to patients in the European Union (EU) due to their importance in the current political landscape. Based on the idea of guaranteeing equitable access to EU citizens for medical treatments, EU Member States (MS) appear to establish and to implement a more effective and non-discriminative legal framework.